B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis

BACKGROUND: Approximately 30% of adult patients with immunoglobulin A (IgA) nephropathy (IgAN) or IgA vasculitis with nephritis (IgAVN) develop end-stage renal disease during long-term follow-up. In particular, patients with nephritic–nephrotic syndrome have an increased risk of rapid progression. C...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundberg, Sigrid, Westergren, Emelie, Smolander, Jessica, Bruchfeld, Annette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
B-Cell Depletion in Glomerulopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469569/
https://www.ncbi.nlm.nih.gov/pubmed/28638602
http://dx.doi.org/10.1093/ckj/sfw106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5469569/
https://www.ncbi.nlm.nih.gov/pubmed/28638602
http://dx.doi.org/10.1093/ckj/sfw106

Ejemplares similares